New Use for DuloxetineAschenbrenner, Diane S., MS, RNAJN The American Journal of Nursing: March 2011 - Volume 111 - Issue 3 - p 23 doi: 10.1097/10.1097/01.NAJ.0000395235.38110.e8 Drug Watch Buy Abstract Author InformationAuthors Article MetricsMetrics Duloxetine (Cymbalta), an antidepressant, is now approved for the treatment of chronic musculoskeletal pain. The drug can have serious adverse effects, including liver damage, allergic reactions, pneumonia, and suicidal thoughts and behavior, but these are rare. Adverse effects more often seen are nausea, dry mouth, insomnia, drowsiness, constipation, fatigue, and dizziness. Diane S. Aschenbrenner is the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. She also coordinates Drug Watch: firstname.lastname@example.org. © 2011 Lippincott Williams & Wilkins, Inc.